By Cecilia Butini

Sartorius AG said Thursday that it is investing around 270 million euros ($302.4 million) through the end of 2024 in an expansion of its business in South Korea.

The German biopharmaceutical company said it plans to launch cell-culture media production and assemble sterile systems for biopharmaceutical manufacturing in the Songdo biopharma hub.

About 750 new jobs will be created at the site in Incheon, South Korea, and construction is planned to begin in the coming year, Sartorius said. Production is set to start by the end of 2024, the company said.

Write to Cecilia Butini at cecilia.butini@wsj.com

(END) Dow Jones Newswires

November 25, 2021 06:35 ET (11:35 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Sartorius (TG:SRT)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Sartorius Charts.
Sartorius (TG:SRT)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Sartorius Charts.